monitor with thiazolidinediones (glitazones)

From Aaushi
Jump to navigation Jump to search
[1]

Monitor

  • serum ALT baseline & periodically
    • every 3-6 months has been suggested

More general terms

References

  1. ↑ Prescriber's Letter 17(7): 2010 Recommended Lab Monitoring for Common Medications Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=260704&pb=PRL (subscription needed) http://www.prescribersletter.com
Retrieved from "https://aaushi.info/w/index.php?title=A25494&oldid=1081708"